RACEMIZATION AND ENANTIOMER SEPARATION OF CLOPIDOGREL

Details for Australian Patent Application No. 2002350250 (hide)

Owner TEVA PHARMACEUTICAL INDUSTRIES LTD.

Inventors VALERIANO, Merli; DAVERIO, Paola; BIANCHI, Stefano

Pub. Number AU-A-2002350250

PCT Number PCT/US02/37680

PCT Pub. Number WO2004/013147

Priority 60/400,738 02.08.02 US

Filing date 22 November 2002

Wipo publication date 23 February 2004

International Classifications

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 031/4365

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/400,738 02.08.02 US

1 April 2004 Application Open to Public Inspection

  Published as AU-A-2002350250

21 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002350251-SYSTEM AND METHOD FOR MONITORING AND CONTROLLING ELECTROSTATIC CHARGE

2002350249-DUAL BATTERY CONFIGURATION TO PROVIDE A LONG-TERM POWER IN A PROGRAMMABLE SMART CARD